GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Labcorp Holdings Inc (NYSE:LH) » Definitions » Cyclically Adjusted Price-to-FCF

Labcorp Holdings (Labcorp Holdings) Cyclically Adjusted Price-to-FCF : 13.74 (As of May. 27, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Labcorp Holdings Cyclically Adjusted Price-to-FCF?

As of today (2024-05-27), Labcorp Holdings's current share price is $199.65. Labcorp Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $14.53. Labcorp Holdings's Cyclically Adjusted Price-to-FCF for today is 13.74.

The historical rank and industry rank for Labcorp Holdings's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

LH' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 10.59   Med: 16.62   Max: 23.33
Current: 13.75

During the past years, Labcorp Holdings's highest Cyclically Adjusted Price-to-FCF was 23.33. The lowest was 10.59. And the median was 16.62.

LH's Cyclically Adjusted Price-to-FCF is ranked better than
77.78% of 63 companies
in the Medical Diagnostics & Research industry
Industry Median: 35.63 vs LH: 13.75

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Labcorp Holdings's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $-1.932. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $14.53 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Labcorp Holdings Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Labcorp Holdings's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labcorp Holdings Cyclically Adjusted Price-to-FCF Chart

Labcorp Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.72 17.94 21.76 14.44 15.59

Labcorp Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.00 14.41 13.93 15.59 15.04

Competitive Comparison of Labcorp Holdings's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Labcorp Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labcorp Holdings's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Labcorp Holdings's Cyclically Adjusted Price-to-FCF falls into.



Labcorp Holdings Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Labcorp Holdings's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=199.65/14.53
=13.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labcorp Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Labcorp Holdings's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.932/131.7762*131.7762
=-1.932

Current CPI (Mar. 2024) = 131.7762.

Labcorp Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 1.846 100.560 2.419
201409 1.422 100.428 1.866
201412 1.944 99.070 2.586
201503 -1.287 99.621 -1.702
201506 3.196 100.684 4.183
201509 2.140 100.392 2.809
201512 2.899 99.792 3.828
201603 0.541 100.470 0.710
201606 2.714 101.688 3.517
201609 1.751 101.861 2.265
201612 3.784 101.863 4.895
201703 1.462 102.862 1.873
201706 2.315 103.349 2.952
201709 3.099 104.136 3.922
201712 4.511 104.011 5.715
201803 1.037 105.290 1.298
201806 2.915 106.317 3.613
201809 1.500 106.507 1.856
201812 3.602 105.998 4.478
201903 0.720 107.251 0.885
201906 1.703 108.070 2.077
201909 3.693 108.329 4.492
201912 4.506 108.420 5.477
202003 1.000 108.902 1.210
202006 2.786 108.767 3.375
202009 7.227 109.815 8.672
202012 6.869 109.897 8.237
202103 10.784 111.754 12.716
202106 3.971 114.631 4.565
202109 6.689 115.734 7.616
202112 6.089 117.630 6.821
202203 2.540 121.301 2.759
202206 4.773 125.017 5.031
202209 3.208 125.227 3.376
202212 6.216 125.222 6.541
202303 0.483 127.348 0.500
202306 2.784 128.729 2.850
202309 1.961 129.860 1.990
202312 4.823 129.419 4.911
202403 -1.932 131.776 -1.932

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Labcorp Holdings  (NYSE:LH) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Labcorp Holdings Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Labcorp Holdings's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Labcorp Holdings (Labcorp Holdings) Business Description

Traded in Other Exchanges
Address
358 South Main Street, Burlington, NC, USA, 27215
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Executives
Peter J Wilkinson officer: SVP, Chief Accounting Officer C/O PHARMACEUTICAL PRODUCT DEVELOPMENT, 929 NORTH FRONT STREET, WILMINGTON NC 28401
Kerrii B Anderson director WENDY'S INTERNATIONAL, INC, 4288 WEST DUBLIN-GRANVILLE RD., DUBLIN OH 43017
Van Der Vaart Sandra D officer: SVP, Global General Counsel 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Paul Rothman director 6 MEADOW ROAD, BALTIMORE MD 21212
Paul R Kirchgraber officer: CEO, Covance Drug Development 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Mark S Schroeder officer: EVP, President-Diagnostics Lab 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Megan D. Bailey officer: EVP, Chief Strategy Officer 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Jonathan P. Divincenzo officer: EVP, Pres, Central Labs & Intl 940 WINTER STREET, PERKINELMER, INC. LEGAL DEPARTMENT, WALTHAM MA 02451
Anita Z Graham officer: EVP, CHRO C/O THE ADT CORPORATION, 1501 YAMATO ROAD, BOCA RATON FL 33431
Thomas Pike officer: Pres & CEO Clinical Business C/O ACCENTURE, 161 N. CLARK STREET, 23RD FLOOR, CHICAGO IL 60601
Kirsten Marie Kliphouse director 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Glenn A Eisenberg officer: Chief Financial Officer, EVP P O BOX 1017, CHARLOTTE NC 28201-1017
Brian J Caveney officer: SVP, Chief Medical Officer 531 SOUTH SPRING STREET, BURLINGTON NC 27215
R Sanders Williams director DUKE UNIVERSITY SCHOOL OF MEDICINE, TRENT DRIVE, DURHAM NC 27706
Amy B. Summy officer: EVP, Chief Marketing Officer 531 SOUTH SPRING STREET, BURLINGTON NC 27215